Lipid-lowering effect of tenofovir in HIV-infected patients

被引：27
|
作者：
Fabbiani, Massimiliano [1 ]
Bracciale, Laura [1 ]
Doino, Maria [1 ]
Sidella, Letizia [1 ]
Farina, Salvatore [1 ]
Di Cristo, Valentina [1 ]
Cauda, Roberto [1 ]
De Luca, Andrea [1 ,2 ]
Di Giambenedetto, Simona [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Ist Clin Malattie Infett, I-00168 Rome, Italy
[2] Siena Univ Hosp, Infect Dis Unit 2, Siena, Italy
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2011年 / 66卷 / 03期
关键词：
cholesterol; simplification; antiretroviral therapy; cardiovascular risk;
D O I：
10.1093/jac/dkq464
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：682 / 683
页数：2
相关论文
共 50 条
  • [31] BNP in HIV-Infected Patients
    Neumann, Till
    Reinsch, Nico
    Neuhaus, Kathrin
    Brockmeyer, Norbert
    Potthoff, Anja
    Esser, Stefan
    Hower, Martin
    Neumann, Anja
    Mostardt, Sarah
    Gelbrich, Goetz
    Erbel, Raimund
    HERZ, 2009, 34 (08) : 634 - 640
  • [32] Radiotherapy for HIV-infected patients
    Quero, L.
    Gobert, A.
    Spano, J. -P.
    CANCER RADIOTHERAPIE, 2018, 22 (6-7): : 496 - 501
  • [33] Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir
    Karrer, U
    Ledergerber, B
    Furrer, H
    Elzi, L
    Battegay, M
    Cavassini, M
    Gayet-Ageron, A
    Hirschel, B
    Schmid, P
    Russotti, M
    Weber, R
    Speck, RF
    AIDS, 2005, 19 (17) : 1987 - 1994
  • [34] Lipid-lowering therapies in development
    Wierzbicki, AS
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (11) : 1405 - 1418
  • [35] Glomerular filtration rates in HIV-infected patients treated with and without tenofovir: a prospective, observational study
    Guaraldi, Giovanni
    Roverato, Alberto
    Giovanardi, Chiara
    Ravera, Federica
    Squillace, Nicola
    Orlando, Gabriella
    Cappelli, Gianni
    Esposito, Roberto
    Palella, Frank
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (02) : 374 - 379
  • [36] Impact of Antiretroviral Treatment Containing Tenofovir Difumarate on the Telomere Length of Aviremic HIV-Infected Patients
    Montejano, Rocio
    Stella-Ascariz, Natalia
    Monge, Susana
    Bernardino, Jose I.
    Perez-Valero, Ignacio
    Montes, Maria L.
    Valencia, Eulalia
    Martin-Carbonero, Luz
    Moreno, Victoria
    Gonzalez-Garcia, Juan
    Arnalich, Francisco
    Mingorance, Jesus
    Pintado Berniches, Laura
    Perona, Rosario
    Arribas, Jose R.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 76 (01) : 102 - 109
  • [37] Lipid-lowering efficacy of atorvastatin
    Adams, Stephen P.
    Tsang, Michael
    Wright, James M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (03):
  • [38] Lipid-lowering Therapies in Myositis
    Mizus, Marisa C.
    Tiniakou, Eleni
    CURRENT RHEUMATOLOGY REPORTS, 2020, 22 (10)
  • [39] Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons
    Choi, Andy I.
    Vittinghoff, Eric
    Deeks, Steven G.
    Weekley, Cristin C.
    Li, Yongmei
    Shlipak, Michael G.
    AIDS, 2011, 25 (10) : 1289 - 1298
  • [40] New lipid-lowering Agents
    Sinning, David
    Landmesser, Ulf
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (02) : 92 - 101
12345